Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer
Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer
Recruiting · NCT07109817 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, skin disorder | Recruiting | Phase 2 | 2026-08-26 | NCT07109817 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Montefiore Medical Center | 93 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Montefiore Medical Center | The Bronx | United States | 198 |